Predictors of liver transplant eligibility for patients with hepatocellular carcinoma in a safety net hospital.
Singal AG, Chan V, Getachew Y, Guerrero R, Reisch JS, Cuthbert JA Dig. Dis. Sci. 2012 Feb 57 2 580-6
Continuous Furosemide Infusion in the Management of Ascites.
Rogers NA, Gupta S, Cuthbert JA Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2012 Feb
Acute kidney injury and chronic kidney disease in hospitalized patients with cirrhosis.
Warner NS, Cuthbert JA, Bhore R, Rockey DC J. Investig. Med. 2011 Dec 59 8 1244-51
Hepatitis A: old and new.
Cuthbert JA Clin. Microbiol. Rev. 2001 Jan 14 1 38-58
Multiple mechanisms, independent of sterol regulatory element binding proteins, regulate low density lipoprotein gene transcription.
Makar RS, Lipsky PE, Cuthbert JA J. Lipid Res. 2000 May 41 5 762-74
Wilson's disease. Update of a systemic disorder with protean manifestations.
Cuthbert JA Gastroenterol. Clin. North Am. 1998 Sep 27 3 655-81, vi-vii
Overexpression of cholesterol 7alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced.
Spady DK, Cuthbert JA, Willard MN, Meidell RS J. Biol. Chem. 1998 Jan 273 1 126-32
Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA, Lipsky PE Cancer Res. 1997 Aug 57 16 3498-505
Hepatitis C: progress and problems.
Cuthbert JA Clin. Microbiol. Rev. 1994 Oct 7 4 505-32
Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation.
Cuthbert JA, Lipsky PE J. Biol. Chem. 1990 Oct 265 30 18568-75